微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 13.52% | -8.46% | 44.91% | 13/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 9.33% | -11.56% | 142.97% | 10/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 3.84% | -9.43% | -78.27% | 16/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 17.67% | 9.96% | 19.63% | 4/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 14.77% | 15.12% | 40% | 7/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 10.55% | 28.35% | 148.82% | 4/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 4.24% | 43.24% | -73.62% | 15/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 16.07% | -9.77% | 25.25% | 16/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 12.83% | -22.34% | 56.08% | 19/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 8.22% | -25.34% | 177.7% | 22/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 2.96% | -38.72% | -83.38% | 38/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 17.81% | 4.27% | 7.81% | 12/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 16.52% | 4.76% | 50.05% | 9/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 11.01% | 8.37% | 127.95% | 11/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 4.83% | 20.15% | -71.72% | 15/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 17.08% | 13.94% | 8.31% | 29/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 15.77% | 27.49% | 55.22% | 16/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 10.16% | 19.95% | 152.74% | 19/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 4.02% | 23.69% | -73.18% | 22/160 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 14.99% | 39.57% | 21.18% | 32/160 | 2.78% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 12.37% | 42.18% | 46.04% | 21/160 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 8.47% | 66.73% | 160.62% | 23/160 | 5.05% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 3.25% | 49.08% | -69.74% | 35/160 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 10.74% | 40.39% | 23.45% | 48/160 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 8.7% | 41.69% | 71.26% | 35/160 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 5.08% | 12.39% | 133.03% | 40/160 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 2.18% | 17.2% | -71.5% | 49/160 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 7.65% | -6.59% | 24.59% | 71/160 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 6.14% | -11.4% | 35.84% | 54/160 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 4.52% | 22.83% | 143.01% | 52/160 | 5.59% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 1.86% | 20% | -77.29% | 47/160 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 8.19% | 6.78% | 18.18% | 67/160 | 6.33% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 6.93% | -8.09% | 88.32% | 40/160 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 3.68% | -22.69% | 137.42% | 52/160 | 3.53% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 1.55% | -24.76% | -79.79% | 50/160 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 7.67% | -24.73% | 1.72% | 59/160 | 11.35% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 7.54% | -45.08% | 58.4% | 35/160 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 4.76% | -32.1% | 131.07% | 38/160 | 4.9% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 2.06% | -70.4% | -79.78% | 38/160 | 2.41% | 华东医药 | 26.63% | 行业排名> |